Williamstown, MA -- (SBWIRE) -- 04/24/2012 -- This analysis examines the historical and forecast performance for Dendreon in the prescription pharmaceutical sector. The profile encompasses key product analysis and forecasts, pipeline assessment, and evaluation of company strategy and financial performance over a 6-year period.

Report Scope:

- Gain insight into Dendreon's strategic outlook across the next 6 years
- Analysis of strategically important company products, supported by patient-based forecasting and key opinion leader interviews

Report Highlights

Strategic evaluation of Dendreon's outlook for the next six years. Assessment of key strengths, weaknesses, opportunities and threats and appraisal of the company's product portfolio, pipeline and commercial relationships.

Reasons to Get this Report:

- Assess how the performance of the Provenge franchise will shape Dendreon's growth prospects through to 2016
- Analyze market factors that are forecast to affect uptake of Provenge.
- See how emerging competitor products in the castrate-resistant prostate cancer market will limit long-term growth for Provenge.

View Full Report Details and Table of Contents

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Dendreon Corporation - Product Pipeline Review - H2 2011
- Dendreon Corporation - Product Pipeline Review - Q4 2010
- Dendreon Corporation (DNDN) - Financial and Strategic SWOT Analysis Review
- Incyte Corporation: PharmaVitae Report
- EQT Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2011
- EnCana Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2011
- El Paso Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2011
- Apache Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2011
- Energen Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2011
- Loews Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2011